Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Naho Ohyanagi"'
Publikováno v:
Respiratory Investigation. 59:454-463
Background Poor control of asthma symptoms is associated with a higher asthma disease burden, and asthma medication adherence is a known predictor for a better control status. This study sought to describe the current asthma control status, self-repo
Autor:
Naho Ohyanagi, Kaori Watanabe, Thomas J. Schall, Mark E. T. Penfold, Yoshishige Miyabe, Kayoko Kaneko, Kenji Matsumoto, Toshihiro Nanki, Akio Matsuda, Nobuyuki Miyasaka
Publikováno v:
Arthritis & Rheumatism. 62:3211-3220
Objective The interaction between CXCL12 and its receptor, CXCR4, in the synovium of patients with rheumatoid arthritis (RA) is important for local inflammatory cell recruitment, angiogenesis, and cytokine production. CXCR7 was recently identified as
Autor:
Tim Edmunds, Naho Ohyanagi, Kohji Itoh, Kaori Fujishima, Kobayashi Toshihide, Tadayasu Togawa, Daisuke Tsuji, Masahiko Ikekita, Kanako Sugawara, Ikuo Kawashima, Michiru Yoshimizu, Youichi Tajima, Sei-ichi Aikawa, Fumiko Matsuzawa, Kunihiko Iwamoto, Toshihiro Suzuki, Hitoshi Sakuraba, Kazuki Ohno
Publikováno v:
Clinica Chimica Acta. 391:68-73
Background Recently, enzyme enhancement therapy (EET) for Pompe disease involving imino sugars, which act as potential inhibitors of acid α-glucosidases in vitro , to improve the stability and/or transportation of mutant acid α-glucosidases in cell
Autor:
Kayoko Kaneko, Toshihiro Nanki, Fumihito Suzuki, Nobuyuki Miyasaka, Miwako Ishido, Naho Ohyanagi, Tetsuo Kubota
Publikováno v:
Arthritis and rheumatism. 60(10)
Objective Polymyositis and dermatomyositis are chronic inflammatory muscle diseases. Retinoids are compounds that bind to the retinoic acid binding site of retinoic acid receptors and have biologic activities similar to those of vitamin A. Recent stu
Autor:
Kazuhiko Watabe, Youichi Tajima, Kanako Sugawara, Tomoko Fukushige, Ikuo Kawashima, Toshihiro Suzuki, Naho Ohyanagi, Takuro Kanekura, Tamotsu Kanzaki, Hitoshi Sakuraba, Tadayasu Togawa
Publikováno v:
Journal of human genetics. 52(12)
Peripheral neuropathy is one of the important manifestations of Fabry disease. Enzyme replacement therapy with presently available recombinant alpha-galactosidases does not always improve the Fabry neuropathy. But the reason has not been determined y